-
srdr.ahrq.gov/projects/1312/studies/147778
January 01, 2015 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … Baseline Health Status
Adults at an increased risk
-
srdr.ahrq.gov/projects/1609/studies/198657
January 01, 1992 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
-
srdr.ahrq.gov/projects/1609/studies/198620
January 01, 2001 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
-
srdr.ahrq.gov/projects/1520/studies/186803
January 01, 2017 - Yes
Low risk of detection bias because outcome assessors were blinded (NCT). … Comments ( 0 ) |
Post/View
Q6: ROBINS-I - Risk of bias judgement for BIAS DUE TO CONFOUNDING … Comments ( 0 ) |
Post/View
Q13: ROBINS-I - Risk of bias judgement for BIAS IN SELECTION OF … Yes
Low risk of detection bias because patients were blinded.
-
srdr.ahrq.gov/projects/1609/studies/198618
interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
-
srdr.ahrq.gov/projects/1609/studies/198655
January 01, 2005 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
-
srdr.ahrq.gov/projects/1609/studies/198617
January 01, 1996 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
-
srdr.ahrq.gov/projects/1609/studies/198654
January 01, 2007 - effectiveness of screening for hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
-
srdr.ahrq.gov/projects/1609/studies/198637
January 01, 2017 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
-
srdr.ahrq.gov/projects/1705/studies/197229
January 01, 2001 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
-
srdr.ahrq.gov/projects/1705/studies/197228
January 01, 1996 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
-
srdr.ahrq.gov/projects/1705/studies/197227
January 01, 2007 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
-
srdr.ahrq.gov/projects/1705/studies/197223
January 01, 2006 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
-
srdr.ahrq.gov/projects/1671
January 08, 2021 - Compared with placebo, triptans resolved pain at 2 hours and 1 day, and increased the risk of mild and … Compared with placebo, NSAIDs probably resolved pain at 2 hours and 1 day, and increased the risk of … No studies evaluated instruments for predicting risk of opioid misuse, opioid use disorder or overdose … , or evaluated risk mitigation strategies to be used when prescribing opioids for the acute treatment … Data can be found in the following links:
https://srdr.s3.amazonaws.com/uploads/01-08-2021/SRDR+-+Risk
-
srdr.ahrq.gov/projects/1609/studies/198619
January 01, 2010 - effectiveness of screening for hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
-
srdr.ahrq.gov/projects/1609/studies/198656
January 01, 2005 - interventions for screen-detected hearing loss differ for subpopulations defined by age, sex, race/ethnicity, risk
-
srdr.ahrq.gov/projects/1705/studies/197224
January 01, 2014 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
-
srdr.ahrq.gov/projects/1705/studies/197225
intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
-
srdr.ahrq.gov/projects/1705/studies/197226
January 01, 1997 - intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk
-
srdr.ahrq.gov/projects/1312/studies/133174
January 01, 2013 - 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … all overweight (BMI 25+), but not obese- not sure if should count as increased risk?